The Perimenopause Protocol: What Science-Backed Supplementation Actually Looks Like for Women Over 40

Perimenopause is not a moment. It is a transition that typically begins in the early to mid-forties and continues until menopause — defined as twelve consecutive months without a menstrual period — which occurs on average at 51 in the UK. The years between are characterised by fluctuating and declining oestrogen and progesterone levels, and the downstream effects of those hormonal changes touch almost every system in the body.

Most of the discussion around perimenopause focuses on HRT — which is, for many women, a highly effective intervention worth discussing with a GP. But there is a parallel conversation that almost never happens: the specific, evidence-backed nutritional and supplementation strategies that address the biological mechanisms driving perimenopausal symptoms, independently of hormonal replacement. This is that conversation.

The Three Biological Mechanisms Behind Perimenopausal Symptoms

Understanding supplementation in perimenopause requires understanding which mechanisms are actually driving which symptoms. The three primary drivers are cortisol dysregulation, NAD+ decline, and metabolic shift.

1. Cortisol Dysregulation

As oestrogen declines, the body increasingly relies on the adrenal glands for hormone production — the adrenals produce a small amount of oestrogen via conversion from androgens. This increased adrenal demand coincides with the chronic stress that characterises many women's lives in their forties, creating a perfect storm for HPA axis dysfunction. Elevated and dysregulated cortisol is directly linked to disrupted sleep, increased central fat deposition, brain fog, and mood instability — symptoms commonly attributed to "the menopause" but driven significantly by the stress response system running on empty.

The intervention: Ashwagandha 600mg (10:1 extract) taken in the evening, targeting cortisol reduction via HPA axis modulation. Clinical trials have demonstrated 15–30% reductions in serum cortisol in chronically stressed subjects, with measurable improvements in sleep quality and anxiety within eight weeks. This is not a general wellness supplement for this population. It is a targeted cortisol intervention.

2. NAD+ Decline

NAD+ levels decline with age for everyone. In women, oestrogen decline accelerates this process — oestrogen upregulates the expression of NAMPT, the rate-limiting enzyme in NAD+ biosynthesis. As oestrogen falls, NAMPT activity falls with it, and NAD+ levels drop faster than age alone would predict. The consequence is mitochondrial inefficiency, increased fatigue, reduced cellular repair capacity, and — critically for perimenopausal women — reduced sirtuin activity, which regulates both metabolic function and inflammatory signalling.

The intervention: NMN 500mg daily, with TMG 600mg to support the methylation cycle that NMN supplementation draws on. This combination addresses the cellular energy deficit at its root rather than masking it with stimulants.

3. Metabolic Shift

Oestrogen plays a significant role in insulin sensitivity and metabolic regulation. As it declines, many women notice that their body composition changes even when diet and exercise remain constant — increased central adiposity, difficulty losing weight, elevated triglycerides. This is not a failure of willpower. It is a change in the metabolic environment driven by hormonal shift.

The intervention: Berberine 600mg (25:1 extract) targets the AMPK pathway — the metabolic master switch — producing measurable improvements in insulin sensitivity, lipid profiles, and weight management in subjects with metabolic dysfunction. The research base is unusually robust for a natural compound, and the mechanism is directly relevant to perimenopausal metabolic change.

The Complete Perimenopause Protocol

Morning: NMN 500mg + TMG 600mg, taken together on an empty stomach or with a light meal. These address cellular energy and methylation throughout the day.

With breakfast or lunch: Berberine 600mg. Always taken with food — AMPK activation in the presence of a meal produces the most consistent metabolic outcomes.

Evening: Ashwagandha 600mg. Cortisol reduction and sleep quality improvement are the priority in the second half of the day.

Run this protocol for a minimum of twelve weeks before assessing. Cortisol improvement is typically felt within four to six weeks. Metabolic changes require eight to twelve. NAD+ replenishment is a sustained process. Read our full guide on why ninety days is the assessment window, not thirty.